Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Breast Magnetic Resonance Imaging Incidental Findings

Breast Magnetic Resonance Imaging Incidental Findings Downloaded from http://journals.lww.com/topicsinmri by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9lBjFbu9i0DAnSw4JagSjiU on 10/30/2020 REVIEW ARTICLE Janet Szabo, MD (TopMagnReson Imaging 2014;23: 361–371) Studies have reported an incidence of contralateral synchronous malignancy detected by preoperative MRI to be in the range of 12–14 3% to 5 %. A contralateral metachronous cancer has been reast magnetic resonance imaging (MRI) is now an integral reported to develop in 5% to 10% of patients with breast cancer B part of breast imaging. It makes valuable contributions in within a 10-year follow-up. This is especially important in high-risk screening; evaluating the extent of disease, positive BRCA1/2 mutation carriers, who have a significantly higher risk surgical margins, and response to neoadjuvant chemotherapy; as 1–6 of developing a contralateral breast cancer (53%) in contrast to well as distinguishing postoperative scar from recurrent disease. the general population (2%). Although the examination is focused on the breast, portions of the neck, thorax, and upper abdomen are also visualized. Just as in EXTRAMAMMARY computed tomography, the issue of the incidental or unexpected finding must be addressed by the reader. Additional extramammary findings also are common, and The detection of these findings during diagnosis and sur- most are benign. Recent retrospective studies of breast MRI exam- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Topics in Magnetic Resonance Imaging Wolters Kluwer Health

Breast Magnetic Resonance Imaging Incidental Findings

Topics in Magnetic Resonance Imaging , Volume 23 (6) – Dec 1, 2014

Loading next page...
 
/lp/wolters-kluwer-health/breast-magnetic-resonance-imaging-incidental-findings-NxrgHQlyQT

References (52)

Publisher
Wolters Kluwer Health
Copyright
© 2014 Lippincott Williams & Wilkins, Inc.
ISSN
0899-3459
eISSN
1536-1004
DOI
10.1097/RMR.0000000000000036
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/topicsinmri by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9lBjFbu9i0DAnSw4JagSjiU on 10/30/2020 REVIEW ARTICLE Janet Szabo, MD (TopMagnReson Imaging 2014;23: 361–371) Studies have reported an incidence of contralateral synchronous malignancy detected by preoperative MRI to be in the range of 12–14 3% to 5 %. A contralateral metachronous cancer has been reast magnetic resonance imaging (MRI) is now an integral reported to develop in 5% to 10% of patients with breast cancer B part of breast imaging. It makes valuable contributions in within a 10-year follow-up. This is especially important in high-risk screening; evaluating the extent of disease, positive BRCA1/2 mutation carriers, who have a significantly higher risk surgical margins, and response to neoadjuvant chemotherapy; as 1–6 of developing a contralateral breast cancer (53%) in contrast to well as distinguishing postoperative scar from recurrent disease. the general population (2%). Although the examination is focused on the breast, portions of the neck, thorax, and upper abdomen are also visualized. Just as in EXTRAMAMMARY computed tomography, the issue of the incidental or unexpected finding must be addressed by the reader. Additional extramammary findings also are common, and The detection of these findings during diagnosis and sur- most are benign. Recent retrospective studies of breast MRI exam-

Journal

Topics in Magnetic Resonance ImagingWolters Kluwer Health

Published: Dec 1, 2014

There are no references for this article.